| Дата выпуска | Название | Автор(ы) |
| 2015 | Anti-osteoporotic action research of nanoparticulated resveratrol and losartan | Koklina, N. U.; Gudyrev, O. S.; Faitelson, A. V.; Rajkumar, D. S. R.; Pokrovskii, M. V.; Korokin, M. V.; Bystrova, N. A. |
| 2011 | Arginase inhibitor in the pharmacological correction of endothelial dysfunction | Pokrovskiy, M. V.; Korokin, M. V.; Tsepeleva, S. A.; Pokrovskaya, T. G.; Kochkarov, V. I. |
| 2019 | Betahistine: targeting on vascular wall aging | Solgalova, A. S.; Soldatov, V. O.; Pokrovskaya, T. G.; Puchenkova, O. A.; Zapesotskaya, S. Ya.; Feitelson, A. V.; Sernov, L. N.; Provotorov, V. Ya.; Pahlevanyan, V. G. |
| 2016 | Cardiovascular effects of an arginase II selective inhibitor | Yakushev, V. I.; Pokrovskii, M. V. |
| 2019 | Combination of captopril and darbepoetin alfa attenuate radiation-induced-endothelial dysfunction | Saroyan, K. V.; Sytnik, M. V.; Miller, E. S.; Puchenkova, O. A.; Soldatov, V. O.; Gashevskaya, A. S.; Artyushkova, E. B.; Gudyrev, O. S. |
| 2020 | Comparative study of the pharmacological effects of Venarus Plus, Venarus, and Detralex on L-NAME-induced endothelial dysfunction, venous tone and platelet aggregation | Lukyanova, Y. S.; Gureev, V. V.; Kolesnichenko, P. D.; Danilenko, L. M.; Gudyrev, O. S.; Pokrovskaya, T. G. |
| 2015 | Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction | Denisiuk, T. A.; Demchenko, S. A.; Saroyan, K. V. |
| 2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Martynova, O. V.; Anciferova, O. E.; Martynov, M. A.; Pokrovskaia, T. G. |
| 2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Pokrovskii, M. V.; Korokin, M. V.; Gudyrev, O. S.; Philippova, O. V.; Dolzhikov, A. A.; Lazareva, G. A. |
| 2019 | Correction of asymmetric dimethylarginine-like pre-eclampsia in rats by micronized purified flavonoids fraction | Antsiferova, O. E.; Yurakova, A. V.; Lukyanova, Y. S.; Gureev, V. V.; Korokin, M. V. |
| 2020 | Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia | Lokteva, T. I.; Rozhkov, I. S.; Gureev, V. V.; Gureeva, A. V.; Zatolokina, M. A. |
| 2018 | Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | Elagin, V. V.; Bratchikov, O. I.; Zatolokina, M. A. |
| 2021 | Correction of the endothelial function and the hemostasis system disorders with ademethionin and taurine in model associated with ADMA-Like preeclampsia | Pokrovskaya, T. G.; Khadieva, T. A.; Gureev, V. V.; Pokrovskiy, V. M.; Patrachanov, E. A.; Kovalenko, I. B.; Shutov, V. I. |
| 2008 | Development of endothelial dysfunction in system Mother-Placenta-Fetus at hypertensive disease in gravidae | Pavlova, T. V.; Selivanova, A. V. |
| 2023 | Dynamics of endothelial function indexes in patients with post-Covid syndrome using a combination drug of ethylmethylhydroxyperidine succinate/vitamin B6 | Mikhailova, L. V.; Belousova, Ya. D.; Moiseeva, E. M.; Tsapkova, A. A.; Gazatova, N. D. |
| 2018 | Endothelial dysfunction: comparative evaluation of ultrasound dopplerography, laser dopplerflowmetry and direct monitoring of arterial pressure for conducting pharmacological tests in rats | Soldatov, V. O.; Malorodova, T. N.; Balamutova, T. I.; Ksenofontov, A. O.; Dovgan, A. P. |
| 2022 | Endothelial dysfunction: developmental mechanisms and therapeutic strategies | Shcheblykin, D. V.; Bolgov, A. A.; Pokrovskii, M. V.; Stepenko, Yu. V.; Tsuverkalova, Y. M.; Shcheblykina, O. V.; Korokina, L. V. |
| 2020 | Endothelial protective properties of short-chain peptides that mimic α-helix B of erythropoietin in experimental preeclampsia | Golubev, I. V.; Gureev, V. V.; Korokin, M. V.; Gureeva, A. V.; Polyanskaya, A. V.; Pokrovskii, M. V.; Lazareva, G. A.; Bystrova, N. A. |
| 2015 | Endothelio- and cardioprotective effects of HMG-CoA reductase inhibitors under the condition of endotoxin-induced endothelial dysfunction | Denisuk, T. A.; Pokrovskii, M. V.; Philippova, O. V.; Dolzhikov, A. A.; Pokrovskaia, T. G.; Korokin, M. V.; Gudyrev, O. S. |
| 2016 | Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia | Provotorov, V. Y.; Korokin, M. V.; Pokrovskii, M. V.; Povetkin, S. V.; Lazareva, G. A. |
